Work

MIRA-1, a p53mut reactivator, is active on Temozolomide-resistant glioblastoma in vitro

Year: 2025

Type: article

Abstract: *This study was supported in part by the “GlioTreat” grant from CGO/Région Pays de la Loire (N°2020_01246—R20060NN).

Source: Molecular Biomedicine

DOI: 10.1186/s43556-025-00335-x

Authors: Juan Perdomo, Catherine Gratas, François Paris, Francois M. Vallette, Lisa Oliver

Institutions: Universidad de Las Palmas de Gran Canaria, Inserm, Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers, Nantes Université, Centre Hospitalier Universitaire de Nantes, Institut de Cancérologie de l'Ouest

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,590

Funders: Centre Hospitalier Universitaire de Nantes, Conseil Régional des Pays de la Loire, Erasmus+

OpenAlex ID: W4416729478

FWCI:

Cites: 5

Cited by:

Related to: